2023 annual financial data
AbCellera Biologics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -115.39%.
Operating income was -237,207,000 USD and net income was -146,398,000 USD.
Operating cash flow was -43,877,000 USD.
Get free AbCellera Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 38,025,000 USD
- Operating income
- -237,207,000 USD
- Net income
- -146,398,000 USD
- Operating cash flow
- -43,877,000 USD